Triple-Negative Breast Cancer: Expert Perspectives On Recent Advances

EP. 1: Standard of Care for Early-Stage TNBC

October 23rd 2020

EP. 2: Role of pCR in Early Stage TNBC Management

October 23rd 2020

EP. 3: Key Trials in ICI-Based Therapy for Early Stage TNBC

October 23rd 2020

EP. 4: Early Stage TNBC: Phase 3 IMpassion031 Study

October 23rd 2020

EP. 5: Role of Immune Checkpoint Inhibitor-Based Therapy in ES TNBC

October 23rd 2020

EP. 6: ICI-Based Therapy in TNBC: Immune-Related Adverse Events

October 23rd 2020

EP. 7: Emerging Data on Biomarkers in ES TNBC

October 23rd 2020

EP. 8: Current Trials for Treatment of Early Stage TNBC

October 23rd 2020

EP. 9: Standard of Care for Metastatic TNBC

October 23rd 2020

EP. 10: KEYNOTE-355 Trial in mTNBC

October 23rd 2020

EP. 11: Testing for PD-L1 Expression in mTNBC

October 23rd 2020

EP. 12: Standard of Care for BRCA+ mTNBC

October 23rd 2020

EP. 13: Sequencing Therapies for mTNBC

October 23rd 2020

EP. 14: Phase 3 ASCENT Trial in mTNBC

October 23rd 2020

EP. 15: Phase 3 ASCENT Trial in mTNBC: Managing Adverse Events

October 23rd 2020

EP. 16: Future Directions for Treatment of TNBC

October 23rd 2020